← All Sponsors

SPONSOR

AstraZeneca

Total Trials

37

Recruiting

37

Phases

Phase 3, Phase 1, Phase 2, Phase 2, Phase 1, Phase 2, Phase 3

Conditions studied: Breast Neoplasms Breast Cancer Neoplasm Metastasis Locally Advanced Cervical Cancer Lymphoma Non-Hodgkin Hodgkin Lymphoma Metastatic Colorectal Cancer Heart Failure and Impaired Kidney Function COPD (Chronic Obstructive Pulmonary Disease)

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Breast Neoplasms

NCT06079671 Phase 3

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

Locally Advanced Cervical Cancer

NCT06137144 Phase 1, Phase 2

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

NCT06792695 Phase 2

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Metastatic Colorectal Cancer

NCT06307652 Phase 3

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Heart Failure and Impaired Kidney Function

Study That Will Evaluate the Brazilian Population With COPD.

COPD (Chronic Obstructive Pulmonary Disease)

NCT07455825 Phase 1

A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Healthy Participants

NCT05952024 Phase 2

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

Diffuse Large B-Cell Lymphoma

NCT06795022 Phase 1, Phase 2

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Hepatocellular Carcinoma

GRANITE: Airsupra Effectiveness in the Real World

Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study

Uncontrolled Asthma

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Systemic Lupus Erythematosus

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

Imjudo & Imfinzi PMS

Hepatocellular Carcinoma

Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer

Observational Study Protocol: LIVER-R

Hepatobiliary Cancers

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Transthyretin Amyloidosis

NCT07363642 Phase 3

Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

NCT03423628 Phase 1

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Recurrent Glioblastoma Multiforme

NCT07205822 Phase 3

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

NCT06713369 Phase 1

AZD5305 hADME in Patients With Advanced Solid Malignancies

Locally Advanced or Metastatic Solid Tumor

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Prostate Cancer

NCT07154901 Phase 1

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Renal Impairment

NCT07285213 Phase 2

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Clostridioides Difficile Infection

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

NCT06448754 Phase 2

Volrustomig Priming Regimens Exploratory Phase II Platform Study

Non-small Cell Lung Cancer

NCT07218900 Phase 2

A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

NCT07423598 Phase 1

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels

Healthy Participants

CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC

Non-Small Cell Lung Cancer

NCT06008093 Phase 3

A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS

Carcinoma, Non-Small-Cell Lung

NCT06749457 Phase 1, Phase 2

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Staphylococcus Aureus

NCT06130553 Phase 1, Phase 2

A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

Advanced Solid Tumors That Are MTAP Deficient

NCT07069712 Phase 2

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Gastroesophageal Adenocarcinoma

NCT06834932 Phase 2, Phase 3

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Pancreatic Cancer

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Respiratory Syncytial Virus (RSV)